In this work, two oximes for the treatment of tabun-inhibited acetylcholinesterase (AChE; EC 3.1.1.7), K074 (1,4-bis(4-hydroxyiminomethylpyridinium)butane dibromide) and K075 ((E)-1,4-bis(4-hydroxyiminomethylpyridinium)but-2-en dibromide), were tested in vitro as reactivators of AChE. Comparison was made with currently used AChE reactivators (pralidoxime, HI-6, methoxime and obidoxime). Human brain homogenate was taken as an appropriate source of the cholinesterases. As resulted, oxime K074 appears to be the most potent reactivator of tabun-inhibited AChE, with reactivation potency comparable to that of obidoxime. A second AChE reactivator, K075, does not attain as great a reactivation potency as K074, although its maximal reactivation (17%) was achieved at relevant concentrations for humans.

Centre of Advanced Studies and Department of Toxicology Faculty of Military Health Sciences University of Defense Trebesska 1575 500 01 Hradec Kralove Czech Republic

Zobrazit více v PubMed

Adv Clin Chem. 2004;38:151-216 PubMed

Arch Toxicol. 1996;70(8):497-503 PubMed

Neurotox Res. 2006 Jan;9(1):59-62 PubMed

J Toxicol Clin Toxicol. 2002;40(6):803-16 PubMed

Bioorg Med Chem Lett. 2005 Jun 2;15(11):2914-7 PubMed

Bioorg Med Chem Lett. 2006 Feb;16(3):622-7 PubMed

J Enzyme Inhib Med Chem. 2003 Dec;18(6):529-35 PubMed

Pharmacol Toxicol. 1999 Jan;84(1):41-5 PubMed

Hum Exp Toxicol. 1999 Sep;18(9):560-5 PubMed

Mini Rev Med Chem. 2006 Mar;6(3):269-77 PubMed

J Appl Toxicol. 2005 Nov-Dec;25(6):491-5 PubMed

Neurotox Res. 2006 Jan;9(1):39-45 PubMed

J Enzyme Inhib Med Chem. 2005 Jun;20(3):233-7 PubMed

Biochem Pharmacol. 1989 Feb 15;38(4):633-40 PubMed

FEBS Lett. 1970 Oct 5;10(3):182-184 PubMed

Basic Clin Pharmacol Toxicol. 2004 Aug;95(2):81-6 PubMed

Drug Chem Toxicol. 1995 May-Aug;18(2-3):119-36 PubMed

Neurotox Res. 2004;6(7-8):565-70 PubMed

Arch Toxicol. 1999 Feb;73(1):7-14 PubMed

Chem Biol. 2003 Jun;10(6):491-502 PubMed

J Enzyme Inhib Med Chem. 2005 Oct;20(5):409-15 PubMed

Toxicology. 1999 Feb 15;132(2-3):111-8 PubMed

Neurotox Res. 2006 Jun;9(4):291-6 PubMed

Biochem Pharmacol. 2004 Dec 1;68(11):2237-48 PubMed

Molecular Modeling Studies on the Multistep Reactivation Process of Organophosphate-Inhibited Acetylcholinesterase and Butyrylcholinesterase

Molecular Modeling and In Vitro Studies of a Neutral Oxime as a Potential Reactivator for Acetylcholinesterase Inhibited by Paraoxon

A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesterase